Worsening of parkinsonism after the use of veralipride for treatment of menopause: Case report

Arquivos de Neuro-Psiquiatria

Volumn 59, Issue 1, 2001, Pages 123-124

  Teive, Hélio A G ^a   Sa, Daniel S ^a  

^a NONE

Author keywords

Menopause; Parkinson's disease; Veralipride

Indexed keywords

DOPAMINE RECEPTOR BLOCKING AGENT; LEVODOPA; VERALIPRIDE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG ACTIVITY; DRUG EFFECT; DRUG RESPONSE; FEMALE; HUMAN; MENOPAUSAL SYNDROME; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; PARKINSON DISEASE; PARKINSONISM; SYMPTOM;

EID: 0035046742     PISSN: 0004282X     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0004-282X2001000100026     Document Type: Article

References (17)

1. Cardoso F, Camargos ST, Silva GA Jr. Etiology of parkinsonism in a Brazilian movement disorders clinic. Arq Neuropsiquiatr 1998;56:171-175.
2. Errea-Abad JM, Ara-Callizo JR, Aibar-Remon C. Drug-induced parkinsonism. clinical aspects compared with Parkinson's disease. Rev Neurol 1998; 27:35-39.
3. Kuzuhara S. Drug-induced parkinsonism. Nippon Rinsho 1997;55: 112-117.
4. Llau ME, Nguyen L, Senard JM, Rascol O, Montastruc JL. Drug-induced parkinsonian syndromes: a 10-year experience at a regional center of pharmaco-vigilance. Rev Neurol 1994;50:757-762.
5. deRijk MC, Tzourio C, Breteler MMB, et al. Prevalence of parkinsonism and Parkinson's disease in Europe : the EUROPARKINSON Collaborative Study. J Neurol Neurosurg Psychiatry 1997;62:10-15.
6. Zichella L, Falaschi P, Fioretti P, et al. Effects of different dopamine agonists and antagonists on post-menopausal hot flushes. Maturitas 1986;8:229-237.
7. David A, Don R, Tajchner G, Weissglas L. Veralipride: alternative antidopaminergic treatment for menopausal symptoms. Am J Obstet Gynecol 1988;158:1107-1115.
8. Delanian L. Clinical study of the action of a new molecule, veralipride on menopausal pscyhofunctional disorders. Sem Hop 1980;56:1468-1470.
9. Uzan S, Salat-Baroux J. The menopause vasomotor flushing: physiopathology and treatment. Rev Fr Gynecol Obstet 1986:81:407-412.
10. Marzolf G, Eberst B, Aerts A, Lecornu C, Mark J, Gandar R. Treatment of menopausal hot flushes with a nonhormonal medication, veralipride. Sem Hop 1982;58:2382-2384.
11. Wesel S, Bosuma WB. The alternative to hormonal treatment of menopausal vasomotor flushes: veralipride. Sem Hop 1983;59:596-599.
12. Marta-Moreno E, Gracia-Naya M, Marzo-Sola ME. Respiratory dyskinesia induced by veralipride. Rev Neurol 1997;25:245-247.
13. Gabellini AS, Pezzoli A, DeMassis P, Sacquegna T. Veralipride-induced tardive dystonia in a patient with bipolar psychosis. Ital J Neurol Sci 1992;13:621-623.
14. Destee A, Warot P. Dyskinesia induced by veralipride (letter). Presse Med 1983;12:1018.
15. Milandre L, Ali Cherif A, Khalil R. Parkinsonian syndrome during a treatment with veralipride. Rev Med Interne 1991;12:157-158.
16. Franchignoni FP, Tesio L. Parkinson syndrome induced by veralipride. Minerva Ginecol 1995;47:277-279.
17. Masmoudi K, Decocq G, Chetaille E, Rosa A, Mizon JP, Andrejak M. Extrapyramidal disorders induced by veralipride (Agreal): apropros of 5 cases. Therapie 1995;50:451-454.